Abiopharma

RedHill Biopharma - RedHills RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohns Disease

Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference

Belden to Acquire RUCKUS Networks from Vistance Networks, Accelerating its Transformation into a Full-Stack Networking Solutions Provider

Vistance Networks to Sell its RUCKUS Networks Business to Belden Inc. for $1.846 Billion

Hippo Reports First Quarter 2026 Financial Results

ConocoPhillips announces first-quarter 2026 results and quarterly dividend

OneWater Marine Inc. Announces Fiscal Second Quarter 2026 Results

CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights

Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results

Catalyst Bancorp, Inc. Announces 2026 First Quarter Results